Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Zealand Pharma (ZLDPF)

OTHER OTC:ZLDPF

ZLDPF

Zealand Pharma

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Zealand Pharma (ZLDPF) Income Statement

85 Followers

Zealand Pharma Income Statement

Last quarter (Q4 2022), Zealand Pharma's total revenue was kr23.93M, a decrease of -55.71% from the same quarter last year. In Q4, Zealand Pharma's net income was kr-342.45M. See Zealand Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	kr 111.09M	kr 103.99M	kr 292.57M	kr 353.31M	kr 41.33M	kr 37.98M
Cost of Revenue	kr 5.25M	kr 0.00	kr 118.81M	kr 90.56M	kr 415.00K	kr 180.24M
Gross Profit	kr 105.83M	kr 103.99M	kr 173.75M	kr 262.75M	kr 40.92M	kr -142.26M
Operating Expense	kr 970.79M	kr 920.59M	kr 1.23B	kr 1.09B	kr 628.86M	kr -794.65M
Operating Income	kr -864.95M	kr -816.60M	kr -1.05B	kr -828.76M	kr -587.94M	kr 652.38M
Net Non Operating Interest Income Expense	kr 96.05M	kr -48.68M	kr 33.65M	kr -6.83M	kr 2.02M	kr -30.79M
Other Income Expense	kr 75.29M	-	kr 8.22M	kr -4.07M	kr 9.24M	kr 3.46M
Pretax Income	kr -1.08B	kr -972.04M	kr -1.03B	kr -839.65M	kr -576.68M	kr 625.05M
Tax Provision	kr 9.28M	kr -6.43M	kr -8.79M	kr 7.08M	kr -5.14M	kr 43.77M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr -1.20B	kr -1.20B	kr -1.02B	kr -846.73M	kr -571.54M	kr 581.28M
Basic EPS	kr -11.90	kr -26.02	kr -23.75K	kr -22.07	kr -16.91	kr 18.94
Diluted EPS	kr -11.90	kr -26.02	kr -23.75K	kr -22.07	kr -16.91	kr 18.94
Basic Average Shares	kr 94.66M	kr 46.20M	kr 42.87B	kr 38.37M	kr 33.80M	kr 30.69M
Diluted Average Shares	kr 94.66M	kr 46.20M	kr 42.87M	kr 38.37M	kr 33.80M	kr 30.70M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 976.04M	kr 920.59M	-	kr 1.18B	kr 629.27M	kr -614.41M
Net Income From Continuing And Discontinued Operation	kr -1.20B	kr -1.20B	kr -1.02B	kr -846.73M	kr -571.54M	kr 581.28M
Normalized Income	kr -845.14M	kr -834.12M	-	kr -843.56M	kr -580.70M	kr 578.06M
Interest Expense	kr 56.46M	kr 56.45M	-	kr 2.90M	kr 3.21M	kr 15.08M
EBIT	kr -1.02B	kr -915.59M	-	kr -836.76M	kr -573.47M	kr 640.13M
EBITDA	kr -999.45M	kr -797.63M	-	kr -836.76M	kr -559.79M	kr 644.64M

Currency in DKK

Zealand Pharma Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing